Creo Medical Group Plc

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: GB00BZ1BLL44

GBP

0.13

0 (0.99%)

May 05

LON

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tristel Plc

Avon Protection Plc

EKF Diagnostics Holdings Plc

Smith & Nephew plc

Creo Medical Group Plc

Inspecs Group Plc

Convatec Group Plc

Advanced Medical Solutions Group Plc

Inspiration Healthcare Group Plc

Belluscura Plc

Tissue Regenix Group Plc

Why is Creo Medical Group Plc ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Operating profit has grown by an annual rate -5.53% of over the last 5 years

Flat results in Jun 25

RAW MATERIAL COST(Y) Grown by 39.54% (YoY)

With ROE of 7.55%, it has a expensive valuation with a 0.97 Price to Book Value

Over the past year, while the stock has generated a return of 18.77%, its profits have risen by 121.2% ; the PEG ratio of the company is 0.1

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Creo Medical Group Plc should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Creo Medical Group Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Creo Medical Group Plc

19.94%

-1.17

55.33%

FTSE 100

18.88%

2.00

10.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

79.03%

EBIT Growth (5y)

-5.53%

EBIT to Interest (avg)

-26.54

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.28

Tax Ratio

10.76%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.97

EV to EBIT

-1.79

EV to EBITDA

-1.98

EV to Capital Employed

0.95

EV to Sales

2.44

PEG Ratio

0.11

Dividend Yield

ROCE (Latest)

-53.14%

ROE (Latest)

7.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-1What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 39.54% (YoY

Here's what is not working for Creo Medical Group Plc

Raw Material Cost

Grown by 39.54% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales